JAMES J LOUGHLIN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES J LOUGHLIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES J LOUGHLIN. JAMES J LOUGHLIN is Director in Tamir Biotechnology, Inc. ($ACEL.OB) and in CELGENE CORP /DE/ ($CELG) and Director in CELGENE CORP /DE/ ($CELG) and Director in Edge Therapeutics, Inc. ($EDGE) and Director in InspireMD, Inc. ($NSPR).
Latest Insider Trading Transactions of JAMES J LOUGHLIN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CELG, NSPR, EDGE, ACEL.OB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | D | 0.00 | 2,068 | 0 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | D | 0.00 | 4,756 | 0 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | D | 0.00 | 970 | 0 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | D | 0.00 | 300 | 0 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | D | 77.38 | 13,266 | 1,026,523 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | D | 121.04 | 10,500 | 1,270,920 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | D | 99.98 | 11,000 | 1,099,780 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | D | 112.16 | 10,000 | 1,121,600 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | D | 88.50 | 20,700 | 1,831,950 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | D | 59.06 | 18,600 | 1,098,516 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | D | 31.80 | 18,600 | 591,480 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | D | 29.00 | 18,600 | 539,400 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | D | 27.69 | 24,666 | 683,002 | 0 | ||
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Sell | D | 0.00 | 1,800 | 0 | 0 | 1.8 K to 0 (-100.00 %) | |
| Nov 22 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Sell | D | 0.00 | 41,861 | 0 | 0 | 41.9 K to 0 (-100.00 %) | |
| Jul 01 2019 | EDGE | PDS Biotechnology ... | LOUGHLIN JAMES J | Director | Option Exercise | A | 5.99 | 9,000 | 53,910 | 9,000 | |
| Jul 01 2019 | EDGE | PDS Biotechnology ... | LOUGHLIN JAMES J | Director | Option Exercise | A | 5.99 | 9,000 | 53,910 | 9,000 | |
| Jun 17 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | M | 0.00 | 2,066 | 0 | 2,068 | ||
| Jun 17 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | M | 0.00 | 375 | 0 | 0 | ||
| Jun 17 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | M | 0.00 | 300 | 0 | 300 | ||
| Jun 17 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | M | 0.00 | 484 | 0 | 970 | ||
| Jun 17 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Buy | M | 0.00 | 2,066 | 0 | 41,861 | 39.8 K to 41.9 K (+5.19 %) | |
| Jun 17 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Buy | M | 0.00 | 375 | 0 | 39,795 | 39.4 K to 39.8 K (+0.95 %) | |
| Jun 17 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Buy | M | 0.00 | 300 | 0 | 39,420 | 39.1 K to 39.4 K (+0.77 %) | |
| Jun 17 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Buy | M | 0.00 | 484 | 0 | 39,120 | 38.6 K to 39.1 K (+1.25 %) | |
| Jun 05 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | A | 0.00 | 4,756 | 0 | 4,756 | ||
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Buy | M | 0.00 | 10,000 | 0 | 26,625 | 16.6 K to 26.6 K (+60.15 %) |
| Feb 11 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | M | 22.47 | 24,666 | 554,245 | 0 | ||
| Feb 11 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Sell | S | 87.29 | 23,466 | 2,048,324 | 38,636 | 62.1 K to 38.6 K (-37.79 %) | |
| Feb 11 2019 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Buy | M | 22.47 | 24,666 | 554,245 | 62,102 | 37.4 K to 62.1 K (+65.89 %) | |
| Aug 15 2018 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Jun 20 2018 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Option Exercise | A | 1.10 | 20,000 | 22,000 | 20,000 | |
| Jun 18 2018 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | M | 0.00 | 334 | 0 | 0 | ||
| Jun 18 2018 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Buy | M | 0.00 | 334 | 0 | 37,436 | 37.1 K to 37.4 K (+0.90 %) | |
| Jun 15 2018 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | M | 0.00 | 2,066 | 0 | 4,134 | ||
| Jun 15 2018 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | M | 0.00 | 375 | 0 | 375 | ||
| Jun 15 2018 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | M | 0.00 | 300 | 0 | 600 | ||
| Jun 15 2018 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | A | 77.38 | 13,266 | 1,026,523 | 13,266 | ||
| Jun 15 2018 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Option Exercise | A | 0.00 | 1,454 | 0 | 1,454 | ||
| Jun 15 2018 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Buy | M | 0.00 | 2,066 | 0 | 37,102 | 35 K to 37.1 K (+5.90 %) | |
| Jun 15 2018 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Buy | M | 0.00 | 375 | 0 | 35,036 | 34.7 K to 35 K (+1.08 %) | |
| Jun 15 2018 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Buy | M | 0.00 | 300 | 0 | 34,661 | 34.4 K to 34.7 K (+0.87 %) | |
| Mar 13 2018 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | M | 27.18 | 9,250 | 251,415 | 0 | |
| Mar 13 2018 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Sell | S | 92.01 | 9,250 | 851,093 | 24,361 | 33.6 K to 24.4 K (-27.52 %) |
| Mar 13 2018 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Buy | M | 27.18 | 9,250 | 251,415 | 33,611 | 24.4 K to 33.6 K (+37.97 %) |
| Jul 05 2017 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | M | 0.00 | 734 | 0 | 0 | |
| Jul 05 2017 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Buy | M | 0.00 | 734 | 0 | 24,361 | 23.6 K to 24.4 K (+3.11 %) |
| Jun 27 2017 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | M | 33.88 | 9,250 | 313,390 | 0 | |
| Jun 27 2017 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | M | 24.97 | 9,250 | 230,973 | 0 | |
| Jun 27 2017 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Sell | S | 133.57 | 9,250 | 1,235,523 | 23,627 | 32.9 K to 23.6 K (-28.14 %) |
| Jun 27 2017 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Buy | M | 33.88 | 9,250 | 313,390 | 32,877 | 23.6 K to 32.9 K (+39.15 %) |
| Jun 27 2017 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Sell | S | 133.57 | 9,250 | 1,235,523 | 23,627 | 32.9 K to 23.6 K (-28.14 %) |
| Jun 27 2017 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Buy | M | 24.97 | 9,250 | 230,973 | 32,877 | 23.6 K to 32.9 K (+39.15 %) |
| Jun 21 2017 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Option Exercise | A | 10.15 | 15,000 | 152,250 | 15,000 | |
| Jun 20 2017 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | M | 0.00 | 333 | 0 | 334 | |
| Jun 20 2017 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Buy | M | 0.00 | 333 | 0 | 23,627 | 23.3 K to 23.6 K (+1.43 %) |
| Jun 16 2017 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | M | 0.00 | 375 | 0 | 750 | |
| Jun 16 2017 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | A | 0.00 | 900 | 0 | 900 | |
| Jun 16 2017 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | A | 121.04 | 10,500 | 1,270,920 | 10,500 | |
| Jun 16 2017 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Buy | M | 0.00 | 375 | 0 | 23,294 | 22.9 K to 23.3 K (+1.64 %) |
| Mar 07 2017 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Buy | P | 9.24 | 3,000 | 27,720 | 6,000 | 3 K to 6 K (+100.00 %) |
| Aug 24 2016 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | M | 25.58 | 7,500 | 191,850 | 0 | |
| Aug 24 2016 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | M | 28.65 | 20,000 | 573,000 | 0 | |
| Aug 24 2016 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Sell | S | 114.10 | 27,500 | 3,137,750 | 22,919 | 50.4 K to 22.9 K (-54.54 %) |
| Aug 24 2016 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Buy | M | 25.58 | 7,500 | 191,850 | 50,419 | 42.9 K to 50.4 K (+17.47 %) |
| Aug 24 2016 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Buy | M | 26.65 | 20,000 | 533,000 | 42,919 | 22.9 K to 42.9 K (+87.26 %) |
| Jul 05 2016 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | M | 0.00 | 733 | 0 | 734 | |
| Jul 05 2016 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Buy | M | 0.00 | 733 | 0 | 22,919 | 22.2 K to 22.9 K (+3.30 %) |
| Jun 23 2016 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Option Exercise | A | 9.34 | 15,000 | 140,100 | 15,000 | |
| Jun 17 2016 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | M | 0.00 | 333 | 0 | 667 | |
| Jun 17 2016 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | A | 0.00 | 1,125 | 0 | 1,125 | |
| Jun 17 2016 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | A | 99.98 | 11,000 | 1,099,780 | 11,000 | |
| Jun 17 2016 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Buy | M | 0.00 | 333 | 0 | 22,186 | 21.9 K to 22.2 K (+1.52 %) |
| Jun 13 2016 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | M | 0.00 | 2,068 | 0 | 0 | |
| Jun 13 2016 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Buy | M | 0.00 | 2,068 | 0 | 21,853 | 19.8 K to 21.9 K (+10.45 %) |
| Mar 23 2016 | NSPR | InspireMD, Inc. | LOUGHLIN JAMES J | Director | Option Exercise | P | 0.59 | 25,000 | 14,750 | 25,000 | |
| Mar 23 2016 | NSPR | InspireMD, Inc. | LOUGHLIN JAMES J | Director | Buy | P | 0.59 | 50,000 | 29,500 | 51,501 | 1.5 K to 51.5 K (+3,331.11 %) |
| Mar 15 2016 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Buy | P | 7.63 | 180 | 1,373 | 3,000 | 2.8 K to 3 K (+6.38 %) |
| Mar 15 2016 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Buy | P | 7.63 | 500 | 3,814 | 2,820 | 2.3 K to 2.8 K (+21.55 %) |
| Mar 15 2016 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Buy | P | 7.64 | 600 | 4,583 | 2,320 | 1.7 K to 2.3 K (+34.88 %) |
| Mar 15 2016 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Buy | P | 7.64 | 1,107 | 8,456 | 1,720 | 613 to 1.7 K (+180.59 %) |
| Mar 15 2016 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Buy | P | 7.64 | 500 | 3,820 | 613 | 113 to 613 (+442.48 %) |
| Mar 15 2016 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Buy | P | 7.63 | 13 | 99 | 113 | 100 to 113 (+13.00 %) |
| Mar 15 2016 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Buy | P | 7.58 | 100 | 758 | 100 | 0 to 100 |
| Feb 24 2016 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Sell | S | 104.12 | 2,100 | 218,652 | 19,785 | 21.9 K to 19.8 K (-9.60 %) |
| Jan 28 2016 | NSPR | InspireMD, Inc. | LOUGHLIN JAMES J | Director | Option Exercise | D | 7.20 | 5,409 | 38,945 | 0 | |
| Jan 28 2016 | NSPR | InspireMD, Inc. | LOUGHLIN JAMES J | Director | Option Exercise | D | 7.80 | 4,875 | 38,025 | 0 | |
| Jan 28 2016 | NSPR | InspireMD, Inc. | LOUGHLIN JAMES J | Director | Option Exercise | D | 27.50 | 7,500 | 206,250 | 0 | |
| Jan 28 2016 | NSPR | InspireMD, Inc. | LOUGHLIN JAMES J | Director | Option Exercise | D | 31.00 | 5,000 | 155,000 | 0 | |
| Jan 28 2016 | NSPR | InspireMD, Inc. | LOUGHLIN JAMES J | Director | Option Exercise | D | 90.00 | 2,500 | 225,000 | 0 | |
| Jan 28 2016 | NSPR | InspireMD, Inc. | LOUGHLIN JAMES J | Director | Grant | A | 0.00 | 1 | 0 | 1,501 | 1.5 K to 1.5 K (+0.07 %) |
| Oct 08 2015 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Option Exercise | C | 0.00 | 16,774 | 0 | 0 | |
| Oct 08 2015 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Buy | J | 8.60 | 364 | 3,130 | 19,625 | 19.3 K to 19.6 K (+1.89 %) |
| Oct 08 2015 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Buy | P | 11.00 | 7,000 | 77,000 | 19,261 | 12.3 K to 19.3 K (+57.09 %) |
| Oct 08 2015 | EDGE | Edge Therapeutics, ... | LOUGHLIN JAMES J | Director | Buy | C | 0.00 | 12,261 | 0 | 12,261 | 0 to 12.3 K |
| Oct 02 2015 | NSPR | InspireMD, Inc. | LOUGHLIN JAMES J | Director | Option Exercise | A | 0.17 | 95,528 | 16,240 | 95,528 | |
| Jul 06 2015 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | M | 0.00 | 733 | 0 | 1,467 | |
| Jul 06 2015 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Buy | M | 0.00 | 733 | 0 | 21,885 | 21.2 K to 21.9 K (+3.47 %) |
| Jul 02 2015 | NSPR | InspireMD, Inc. | LOUGHLIN JAMES J | Director | Option Exercise | A | 0.28 | 58,176 | 16,289 | 58,176 | |
| Jun 19 2015 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | A | 0.00 | 1,000 | 0 | 1,000 | |
| Jun 19 2015 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | A | 112.16 | 10,000 | 1,121,600 | 10,000 | |
| Jun 16 2015 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | M | 0.00 | 2,068 | 0 | 0 | |
| Jun 16 2015 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Option Exercise | M | 0.00 | 2,066 | 0 | 2,068 | |
| Jun 16 2015 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Buy | M | 0.00 | 2,068 | 0 | 21,152 | 19.1 K to 21.2 K (+10.84 %) |
| Jun 16 2015 | CELG | CELGENE CORP /DE/ | LOUGHLIN JAMES J | Director | Buy | M | 0.00 | 2,066 | 0 | 19,084 | 17 K to 19.1 K (+12.14 %) |
| Apr 06 2015 | NSPR | InspireMD, Inc. | LOUGHLIN JAMES J | Director | Option Exercise | A | 0.32 | 51,413 | 16,452 | 51,413 | |
| Feb 12 2007 | ACEL.OB | Tamir Biotechnolog ... | LOUGHLIN JAMES J | Director | Option Exercise | A | 1.49 | 15,000 | 22,350 | 15,000 | |
| Jan 04 2007 | ACEL.OB | Tamir Biotechnolog ... | LOUGHLIN JAMES J | Director | Option Exercise | A | 1.60 | 20,000 | 32,000 | 20,000 | |
| Jul 26 2006 | ACEL.OB | Tamir Biotechnolog ... | LOUGHLIN JAMES J | Director | Buy | P | 2.04 | 4,280 | 8,731 | 10,000 | 5.7 K to 10 K (+74.83 %) |
| Jul 26 2006 | ACEL.OB | Tamir Biotechnolog ... | LOUGHLIN JAMES J | Director | Buy | P | 2.03 | 3,220 | 6,537 | 5,720 | 2.5 K to 5.7 K (+128.80 %) |
| Jan 04 2006 | ACEL.OB | Tamir Biotechnolog ... | LOUGHLIN JAMES J | Director | Option Exercise | A | 1.89 | 20,000 | 37,800 | 20,000 | |
| Jan 04 2005 | ACEL.OB | Tamir Biotechnolog ... | LOUGHLIN JAMES J | Director | Option Exercise | A | 4.38 | 20,000 | 87,600 | 20,000 | |
| Sep 22 2004 | ACEL.OB | Tamir Biotechnolog ... | LOUGHLIN JAMES J | Director | Buy | P | 4.60 | 1,100 | 5,060 | 2,500 | 1.4 K to 2.5 K (+78.57 %) |
| Sep 22 2004 | ACEL.OB | Tamir Biotechnolog ... | LOUGHLIN JAMES J | Director | Buy | P | 4.50 | 1,400 | 6,300 | 1,400 | 0 to 1.4 K |
| Jan 16 2004 | ACEL.OB | Tamir Biotechnolog ... | LOUGHLIN JAMES J | Director | Option Exercise | A | 3.74 | 13,750 | 51,425 | 13,750 |
Page: 1